|
West Nile Virus: Review of the Literature
|
journal
|
July 2013 |
|
Recognition of cytosolic DNA by cGAS and other STING-dependent sensors: HIGHLIGHTS
|
journal
|
January 2014 |
|
Diversity within Natural Populations of Eastern Equine Encephalomyelitis Virus
|
journal
|
August 1993 |
|
Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin Vivo
|
journal
|
December 1997 |
|
A New Strategy in Design of (+)RNA Virus Infectious Clones Enabling Their Stable Propagation in E. coli
|
journal
|
March 2001 |
|
Electroporation for therapeutic DNA vaccination in patients
|
journal
|
December 2014 |
|
Climate change and threat of vector-borne diseases in India: are we prepared?
|
journal
|
February 2010 |
|
Development of an attenuated strain of chikungunya virus for use in vaccine production
|
journal
|
September 1986 |
|
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
|
journal
|
March 1996 |
|
Chikungunya in Europe
|
journal
|
March 2008 |
|
Chikungunya: a re-emerging virus
|
journal
|
February 2012 |
|
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
|
journal
|
June 2023 |
|
The prime-boost strategy: exciting prospects for improved vaccination
|
journal
|
April 2000 |
|
A ‘minimal’ approach in design of flavivirus infectious DNA
|
journal
|
December 2001 |
|
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
|
journal
|
August 2000 |
|
TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus
|
journal
|
February 1999 |
|
Clinical burden of chikungunya virus infection
|
journal
|
January 2008 |
|
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
|
journal
|
April 2024 |
|
Present and future arboviral threats
|
journal
|
February 2010 |
|
Yellow Fever: A Perennial Threat
|
journal
|
November 2022 |
|
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives
|
journal
|
December 2023 |
|
Intracellular sensing of viral DNA by the innate immune system
|
journal
|
December 2014 |
|
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention
|
journal
|
August 2013 |
|
An imported case of Chikungunya fever from Madagascar: Use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries
|
journal
|
January 2009 |
|
Chikungunya Virus: Possible Impact on Transfusion Medicine
|
journal
|
January 2010 |
|
Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases
|
journal
|
October 2007 |
|
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
|
journal
|
September 2008 |
|
Development pathway for biodefense vaccines
|
journal
|
November 2009 |
|
Vaccines for Venezuelan equine encephalitis
|
journal
|
November 2009 |
|
Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates
|
journal
|
October 2010 |
|
Stability of RNA virus attenuation approaches
|
journal
|
March 2011 |
|
US Military contributions to the global response to pandemic chikungunya
|
journal
|
October 2012 |
|
Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine
|
journal
|
February 2013 |
|
Vaccination of healthcare personnel: Spotlight on groups with underlying conditions
|
journal
|
July 2014 |
|
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014
|
journal
|
April 2015 |
|
Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus
|
journal
|
September 2015 |
|
Molecular characterization of the 17D-204 yellow fever vaccine
|
journal
|
October 2015 |
|
Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer
|
journal
|
October 2015 |
|
Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome
|
journal
|
May 2019 |
|
Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge
|
journal
|
April 2020 |
|
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice
|
journal
|
November 2014 |
|
Live attenuated vaccines: Historical successes and current challenges
|
journal
|
May 2015 |
|
Development of a human live attenuated West Nile infectious DNA vaccine
|
journal
|
October 2015 |
|
Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein
|
journal
|
January 2016 |
|
Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design
|
journal
|
January 2016 |
|
Next generation sequencing of DNA-launched Chikungunya vaccine virus
|
journal
|
March 2016 |
|
Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice
|
journal
|
December 2017 |
|
Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model
|
journal
|
December 2003 |
|
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
|
journal
|
January 2010 |
|
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
|
journal
|
August 2011 |
|
Vaccines: past, present and future
|
journal
|
April 2005 |
|
DNA vaccines: ready for prime time?
|
journal
|
October 2008 |
|
The regulation and functions of the nuclear RNA exosome complex
|
journal
|
January 2016 |
|
Transmission cycles, host range, evolution and emergence of arboviral disease
|
journal
|
October 2004 |
|
The arrival, establishment and spread of exotic diseases: patterns and predictions
|
journal
|
April 2010 |
|
Biology and pathogenesis of chikungunya virus
|
journal
|
July 2010 |
|
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
|
journal
|
July 2023 |
|
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
|
journal
|
November 2022 |
|
Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine — Preliminary Report
|
journal
|
October 2017 |
|
Venezuelan equine encephalitis emergence: Enhanced vector infection from a single amino acid substitution in the envelope glycoprotein
|
journal
|
July 2004 |
|
Arbovirus high fidelity variant loses fitness in mosquitoes and mice
|
journal
|
September 2011 |
|
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus
|
journal
|
August 2003 |
|
DNA-launched live-attenuated vaccines for biodefense applications
|
journal
|
April 2016 |
|
The use of electroporation to deliver DNA-based vaccines
|
journal
|
December 2023 |
|
Chikungunya vaccines in development
|
journal
|
November 2015 |
|
Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
|
journal
|
June 2020 |
|
Prophylaxis and Therapy for Chikungunya Virus Infection
|
journal
|
August 2009 |
|
Clinical Applications of DNA Vaccines: Current Progress
|
journal
|
July 2011 |
|
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
|
journal
|
June 2006 |
|
Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study
|
journal
|
June 2023 |
|
DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice
|
journal
|
February 2014 |
|
Raising Expectations For Subunit Vaccine
|
journal
|
November 2014 |
|
Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone
|
journal
|
April 2015 |
|
Genetic divergence of Chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic
|
journal
|
July 2007 |
|
DNA vaccines: an historical perspective and view to the future: The past and future of DNA vaccines
|
journal
|
December 2010 |
|
The landscape of transcription errors in eukaryotic cells
|
journal
|
October 2017 |
|
ENTOMOLOGY: A Mosquito Goes Global
|
journal
|
May 2008 |
|
Unfilled Vials
|
journal
|
January 2016 |
|
A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates
|
journal
|
March 2011 |
|
Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines
|
journal
|
July 2015 |
|
Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
|
journal
|
November 2010 |
|
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine
|
journal
|
October 2007 |
|
Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice
|
journal
|
March 2014 |
|
Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein
|
journal
|
June 2012 |
|
Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine
|
journal
|
August 2001 |
|
Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses
|
journal
|
December 2001 |
|
An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector
|
journal
|
October 2003 |
|
Attenuation of Bunyavirus Replication by Rearrangement of Viral Coding and Noncoding Sequences
|
journal
|
June 2005 |
|
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
|
journal
|
January 1993 |
|
A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development
|
journal
|
August 2016 |
|
The alphaviruses: gene expression, replication, and evolution
|
journal
|
September 1994 |
|
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
|
journal
|
December 2015 |
|
V ENEZUELAN E QUINE E NCEPHALITIS
|
journal
|
January 2004 |
|
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
|
journal
|
January 2013 |
|
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss
|
journal
|
December 2014 |
|
Vaccination in children with allergy to non active vaccine components
|
journal
|
February 2015 |
|
Chikungunya: A Potentially Emerging Epidemic?
|
journal
|
April 2010 |
|
A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates
|
journal
|
January 2011 |
|
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
|
journal
|
April 2015 |
|
Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate
|
journal
|
September 2015 |
|
The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines
|
journal
|
January 2022 |
|
Epidemiology of yellow fever virus in humans, arthropods, and non-human primates in sub-Saharan Africa: A systematic review and meta-analysis
|
journal
|
July 2022 |
|
Clinical potential of electroporation for gene therapy and DNA vaccine delivery
|
journal
|
December 2015 |
|
Clinical vaccine development for H5N1 influenza
|
journal
|
July 2013 |
|
Production and purification of plasmid DNA vaccines: is there scope for further innovation?
|
journal
|
October 2014 |
|
Electroporation-enhanced delivery of nucleic acid vaccines
|
journal
|
December 2014 |
|
DNA vaccines for biodefense
|
journal
|
December 2009 |
|
New Japanese encephalitis vaccines: alternatives to production in mouse brain
|
journal
|
March 2011 |
|
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
|
journal
|
August 2011 |
|
Chikungunya virus and prospects for a vaccine
|
journal
|
September 2012 |
|
Synthetic DNA vaccine strategies against persistent viral infections
|
journal
|
May 2013 |
|
Improving DNA Vaccine Performance Through Vector Design
|
journal
|
August 2014 |
|
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
|
journal
|
May 2002 |
|
Characterization of Virulent West Nile Virus Kunjin Strain, Australia, 2011
|
journal
|
May 2012 |
|
The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus
|
journal
|
November 2023 |
|
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
|
journal
|
November 2023 |
|
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits
|
journal
|
March 2022 |
|
Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview
|
journal
|
October 2023 |
|
The Present and Future of Yellow Fever Vaccines
|
journal
|
September 2021 |
|
Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development
|
journal
|
February 2019 |
|
Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources
|
journal
|
July 2021 |
|
Ecology of West Nile Virus in North America
|
journal
|
September 2013 |
|
Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes
|
journal
|
March 2020 |
|
Development of Pandemic Vaccines: ERVEBO Case Study
|
journal
|
February 2021 |
|
DNA vaccines: A simple DNA sensing matter?
|
journal
|
October 2013 |
|
Mesenteronal Infection Threshold of an Epizootic Strain of Venezuelan Encephalitis Virus in Culex (Melanoconion) Taeniopus Mosquitoes and Its Implication to the Apparent Disappearance of This Virus Strain from an Enzootic Habitat in Guatemala
|
journal
|
September 1982 |
|
Vector Competence of Culex (Melanoconion) Taeniopus for Allopatric and Epizootic Venezuelan Equine Encephalomyelitis Viruses
|
journal
|
January 1987 |
|
Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks.
|
journal
|
March 1999 |
|
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
|
journal
|
June 2000 |
|
Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
|
journal
|
January 2001 |
|
Vector Competence of Culex (Melanoconion) taeniopus for Equine-Virulent Subtype IE Strains of Venezuelan Equine Encephalitis Virus
|
journal
|
June 2010 |
|
History of U.S. Military Contributions to the Study of Viral Encephalitis
|
journal
|
April 2005 |
|
Serologic Evidence of Venezuelan Equine Encephalitis in some wild and Domestic Populations of Southern Texas
|
journal
|
April 1975 |